| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |